SCHEMBL7529052

SCHEMBL7529052

COc1ccc(C(=O)c2nc(N)c3ncn(CC(=O)O)c3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.46
PDE8B O95263 1/20 0.43
NSD3 Q9BZ95 1/20 0.42
EGFR P00533 1/20 0.41
PDE8A O60658 1/20 0.41
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.38
NPC1 O15118 2/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
RAB9A P51151 1/20 0.38
PI4KA P42356 1/20 0.38
PI4K2B Q8TCG2 1/20 0.38
PI4K2A Q9BTU6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL454082 0.86 EGFR (0.54) PTGS2EGFRCDK2FLT4KDR
SCHEMBL6046942 0.77 PDE8B (0.40) PDE8BNSD3CCNA2CDK2KMT2A
SCHEMBL454627 0.77 EGFR (0.47) EGFRCDK2FLT4KDRNPC1
SCHEMBL1672138 0.73 CDK1 (0.62) EGFRCDK2LMNAHSP90AA1HSP90AB1
SCHEMBL2152998 0.72 EGFR (0.44) EGFRKMT2AMEN1LMNAMAPT
SCHEMBL4735463 0.71 CDK1 (0.49) EGFRCDK2LMNAPI4KAPI4K2B
SCHEMBL7528356 0.70 MAPK14 (0.45) PTGS2CCNA2CDK2KMT2AMEN1
SCHEMBL23885478 0.70 CDK1 (0.44) EGFRCDK2LMNA
SCHEMBL8768015 0.70 HSP90AB1 (0.52) CDK2FLT4KDRHSP90AA1HSP90AB1
SCHEMBL7640806 0.70 KMT2A (0.44) CCNA2CDK2KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6465650-B1 INTERMEDIATE STEPS IN PREPARING PEPTIDE NUCLEIC ACIDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-10-15 US disclosed
EP-0761681-B1 Process for the preparation of substituted derivatives of N-ethylglycine HOECHST AG (DE) 2002-03-13 EP disclosed
EP-0761681-A2 Process for the preparation of substituted derivatives of N-ethylglycine HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-12 EP disclosed